120 related articles for article (PubMed ID: 33386231)
1. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Clin Breast Cancer; 2021 Oct; 21(5):399-407.e2. PubMed ID: 33386231
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
3. Efp/TRIM25 and Its Related Protein, TRIM47, in Hormone-Dependent Cancers.
Azuma K; Inoue S
Cells; 2022 Aug; 11(15):. PubMed ID: 35954308
[TBL] [Abstract][Full Text] [Related]
4. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
6. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
[TBL] [Abstract][Full Text] [Related]
7. Efp as a primary estrogen-responsive gene in human breast cancer.
Ikeda K; Orimo A; Higashi Y; Muramatsu M; Inoue S
FEBS Lett; 2000 Apr; 472(1):9-13. PubMed ID: 10781795
[TBL] [Abstract][Full Text] [Related]
8. Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Pathol Int; 2021 Jan; 71(1):60-69. PubMed ID: 33159706
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
[TBL] [Abstract][Full Text] [Related]
10. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.
Thomson SD; Ali S; Pickles L; Taylor J; Pace PE; Lymboura M; Shousha S; Coombes RC
Int J Cancer; 2001 Jan; 91(2):152-8. PubMed ID: 11146438
[TBL] [Abstract][Full Text] [Related]
11. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
[TBL] [Abstract][Full Text] [Related]
12. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation.
Wu SF; Xia L; Shi XD; Dai YJ; Zhang WN; Zhao JM; Zhang W; Weng XQ; Lu J; Le HY; Tao SC; Zhu J; Chen Z; Wang YY; Chen S
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14395-14404. PubMed ID: 32513696
[TBL] [Abstract][Full Text] [Related]
13. Positive regulatory role of c-Src-mediated TRIM25 tyrosine phosphorylation on RIG-I ubiquitination and RIG-I-mediated antiviral signaling pathway.
Lee NR; Choi JY; Yoon IH; Lee JK; Inn KS
Cell Immunol; 2018 Oct; 332():94-100. PubMed ID: 30100205
[TBL] [Abstract][Full Text] [Related]
14. The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.
Shu XS; Zhao Y; Sun Y; Zhong L; Cheng Y; Zhang Y; Ning K; Tao Q; Wang Y; Ying Y
J Pathol; 2018 Jan; 244(1):36-48. PubMed ID: 28940253
[TBL] [Abstract][Full Text] [Related]
15. RIPLET, and not TRIM25, is required for endogenous RIG-I-dependent antiviral responses.
Hayman TJ; Hsu AC; Kolesnik TB; Dagley LF; Willemsen J; Tate MD; Baker PJ; Kershaw NJ; Kedzierski L; Webb AI; Wark PA; Kedzierska K; Masters SL; Belz GT; Binder M; Hansbro PM; Nicola NA; Nicholson SE
Immunol Cell Biol; 2019 Oct; 97(9):840-852. PubMed ID: 31335993
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
17. Systemic distribution of estrogen-responsive finger protein (Efp) in human tissues.
Shimada N; Suzuki T; Inoue S; Kato K; Imatani A; Sekine H; Ohara S; Shimosegawa T; Sasano H
Mol Cell Endocrinol; 2004 Apr; 218(1-2):147-53. PubMed ID: 15130519
[TBL] [Abstract][Full Text] [Related]
18. Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP.
Nakajima A; Maruyama S; Bohgaki M; Miyajima N; Tsukiyama T; Sakuragi N; Hatakeyama S
Biochem Biophys Res Commun; 2007 May; 357(1):245-51. PubMed ID: 17418098
[TBL] [Abstract][Full Text] [Related]
19. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
20. Interferon- Stimulation Elicited by the Influenza Virus Is Regulated by the Histone Methylase Dot1L through the RIG-I-TRIM25 Signaling Axis.
Marcos-Villar L; Nistal-Villan E; Zamarreño N; Garaigorta U; Gastaminza P; Nieto A
Cells; 2020 Mar; 9(3):. PubMed ID: 32188146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
